Curzion Pharmaceuticals

Treatment of Systemic Sclerosis.

Sectors
Healthcare
Life Sciences
First Invested
2019
Early
Company Status
Acquired
Acquired by Horizon Therapeutics
Associated Team
Edward Mathers